Suppr超能文献

来自印度南部的一系列顺势疗法药物相关严重药物性肝损伤。

A series of homeopathic remedies-related severe drug-induced liver injury from South India.

机构信息

Division of Complementary and Alternative Medicine (Homoeopathy), Department of Clinical Research, The Liver Institute, Center for Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva, Kerala, India.

Division of Complementary and Alternative Medicine (Ayurveda), Department of Clinical Research, The Liver Institute, Center for Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva, Kerala, India.

出版信息

Hepatol Commun. 2023 Feb 9;7(3):e0064. doi: 10.1097/HC9.0000000000000064. eCollection 2023 Mar 1.

Abstract

INTRODUCTION

Homeopathic remedies are highly diluted formulations without proven clinical benefits, traditionally believed not to cause adverse events. Nonetheless, published literature reveals severe local and non-liver-related systemic side effects. We present the first series on homeopathy-related severe drug-induced liver injury (DILI) from a single center.

METHODS

A retrospective review of records from January 2019 to February 2022 identified 9 patients with liver injury attributed to homeopathic formulations. Competing causes were comprehensively excluded. Chemical analysis was performed on retrieved formulations using triple quadrupole gas chromatography-mass spectrometry and inductively coupled plasma atomic emission spectroscopy.

RESULTS

Males predominated with a median age of 54 years. The most typical clinical presentation was acute hepatitis, followed by acute on chronic liver failure. All patients developed jaundice, and ascites were notable in one-third of the patients. Five patients had underlying chronic liver disease. COVID-19 prevention was the most common indication for homeopathic use. Probable DILI was seen in 77.8%, and hepatocellular injury predominated (66.7%). Four (44.4%) patients died (3 with chronic liver disease) at a median follow-up of 194 days. Liver histopathology showed necrosis, portal and lobular neutrophilic inflammation, and eosinophilic infiltration with cholestasis. A total of 29 remedies were consumed between 9 patients, and 15 formulations were analyzed. Toxicology revealed industrial solvents, corticosteroids, antibiotics, sedatives, synthetic opioids, heavy metals, and toxic phyto-compounds, even in 'supposed' ultra-dilute formulations.

CONCLUSION

Homeopathic remedies potentially result in severe liver injury, leading to death in those with underlying liver disease. The use of mother tinctures, insufficient dilution, poor manufacturing practices, adulteration and contamination, and the presence of direct hepatotoxic herbals were the reasons for toxicity. Physicians, the public, and patients must realize that Homeopathic drugs are not 'gentle placebos.'

摘要

介绍

顺势疗法药物是高度稀释的配方,没有经过临床验证的疗效,但传统上认为不会引起不良反应。然而,已发表的文献揭示了严重的局部和非肝脏相关的全身副作用。我们首次报告了来自单一中心的与顺势疗法相关的严重药物性肝损伤(DILI)系列病例。

方法

回顾性分析了 2019 年 1 月至 2022 年 2 月的病历,确定了 9 例归因于顺势疗法制剂的肝损伤患者。综合排除了其他竞争原因。使用三重四极杆气相色谱-质谱联用和电感耦合等离子体原子发射光谱法对回收制剂进行化学分析。

结果

男性为主,中位年龄为 54 岁。最典型的临床表现为急性肝炎,其次为急性加重的慢性肝衰竭。所有患者均出现黄疸,三分之一的患者出现腹水。5 例患者存在慢性肝病。预防 COVID-19 是最常见的顺势疗法使用指征。77.8%的患者被认为是可能的 DILI,肝损伤为主(66.7%)。4 例(44.4%)患者死亡(3 例有慢性肝病),中位随访时间为 194 天。肝组织病理学显示坏死、门管区和小叶中性粒细胞炎症和嗜酸性粒细胞浸润伴胆汁淤积。9 例患者共服用 29 种药物,分析了 15 种制剂。毒理学检测到工业溶剂、皮质类固醇、抗生素、镇静剂、合成阿片类药物、重金属和有毒植物化合物,甚至在“据称”的超稀释制剂中也存在。

结论

顺势疗法药物可能导致严重的肝损伤,导致有基础肝病的患者死亡。母酊剂、稀释不足、不良生产实践、掺假和污染以及直接肝毒性草药的存在是导致毒性的原因。医生、公众和患者必须认识到,顺势疗法药物并非“温和的安慰剂”。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/924b/9916127/e57e3606940c/hc9-7-e0064-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验